AGP Executive Report

Rare-disease drug deal: LEO Pharma agreed to buy worldwide rights to Tanabe’s oral rare-skin drug dersimelagon for up to $435m, adding a late-stage pipeline asset for erythropoietic protoporphyria and X-linked protoporphyria that’s under US FDA review with a potential 2027 launch. Mental health & chronic disease: A large Danish registry study links endometriosis with higher use of antidepressant and anxiety medication not just after diagnosis but up to a decade earlier, pointing to a long-running mental health toll. Medication safety question: Research raises concerns about whether combining clozapine with GLP-1 weight-loss drugs could worsen gut-motility problems, as both can affect gastrointestinal movement. Public health rollout: UNICEF reports the first shipment of HPV vaccine vials has arrived in Papua New Guinea, with a national rollout starting in September 2026 to protect girls against cervical cancer. IVF oversight alarm: A BBC investigation alleges IVF patients in northern Cyprus may have received wrong sperm or egg donors, with parents raising concerns about misleading practices at a clinic. Denmark in humanitarian spotlight: Denmark will participate as country guest of honour at DIHAD 2026 in Dubai, focusing on health, technology and innovation in humanitarian action.

Denmark Health Policy: Denmark has launched a unified emergency psychiatric hotline, aiming to make urgent mental-health support easier to reach when people need it most. Vaccine Hesitancy Watch: In the US, kindergarten vaccine exemptions hit another record high, as federal moves would shift childhood immunizations toward fewer combined shots and more visits—raising alarms amid a measles resurgence. Cancer & Biotech: Danish biotech Evaxion scrapped its solid-tumor vaccine EVX-03 to refocus on EVX-05, an off-the-shelf glioblastoma vaccine developed with Duke University. Sleep Medicine: Eurofarma and Eisai bring insomnia drug Dayvigo (lemborexant) to Brazil, targeting patients who struggle with next-day effects seen with older options. Infection Control Tech: TOMI Environmental Solutions says its Binary Ionization Technology gained formal approval in Ireland under EU biocidal rules, expanding access across multiple European markets including Denmark. Local Health & Care: A new study links higher body fat with lower sperm count, adding to the growing picture of how metabolic health affects fertility. Public Health Logistics: UNICEF reports Papua New Guinea received its first 100,000 HPV vaccine vials, with rollout planned from September to prevent cervical cancer.

Public Health Alert: Denmark-linked research finds higher body fat percentage is linked to lower sperm count and hormone changes, based on measurements from 1,058 young Danish men—suggesting body fat may be a better reproductive health marker than BMI. Food & Water Safety: Authorities in Germany warn of potentially toxic blue-green algae (cyanobacteria) in the Baltic Sea and nearby lakes, advising people to avoid swimming and to keep children off shore areas if blooms appear. Product Safety: French regulators issued warnings after reports of serious burns from “squishy” anti-stress toys that burst—following UK burn-centre concerns about children heating these toys. Community & Care: A Danish-run padel community in Hua Hin highlights how sport can build local health and social connection, with a focus on newcomers and experienced players. Healthcare Access (US): A commentary argues the crisis isn’t only insurance costs, but the inability of insured patients to get timely appointments—turning healthcare access into a practical barrier. Denmark Immigration: Denmark updated its Positive List for Skilled Work for 2026, expanding over 60 shortage professions for residence and work permits.

Denmark Immigration Update: Denmark has updated its Positive List for Skilled Work in 2026, adding 60+ shortage professions that can qualify foreign workers for residence and work permits. Public Health Alert: Authorities in Germany warned swimmers to avoid blue-green algae (cyanobacteria) in the Baltic Sea and nearby lakes, citing skin irritation and possible toxin-related illness. Reproductive Health Research: A Danish study of 1,058 young men suggests body fat percentage may predict sperm count and hormone changes better than BMI, with higher body fat linked to lower sperm counts even in “normal BMI” cases. HIV Milestone: UNAIDS highlights Cambodia’s achievement of the 95-95-95 HIV targets, stressing leadership plus community partnerships as the driver of sustainable progress. Safety & Care in Denmark: A Danish teen is in custody after the stabbing death of a 16-year-old near a school party in Roskilde, with police investigating a suspected dispute. Weight-Loss Nutrition Study: A JAMA Network Open trial found a low-fat vegan diet produced weight loss comparable to semaglutide over 16 weeks. Climate & Health Risks: Wildfires on Greece’s Salamis island killed two people and sent hundreds to evacuation, with burn injuries reported.

Weight-loss Diet vs. Semaglutide: A 16-week JAMA Network Open trial found a low-fat vegan diet led to weight loss comparable to semaglutide, with participants dropping about 5.9 kg on average. Public Health Partnerships: Ho Chi Minh City joined Novo Nordisk’s Cities for Better Health network to tackle rising overweight and obesity, especially among schoolchildren. Greenland Energy & Governance: Greenland is weighing a response after a Texas-linked company shipped drilling equipment without authorization, raising questions about permits and environmental protections. Screen-Time Guidance: Japan’s Toyoake city found only about 5% of residents cut smartphone and game use after a nonbinding two-hours-a-day recommendation. Injury & Safety in Denmark: A 16-year-old is in custody after a stabbing death of another 16-year-old near a Roskilde school party, with police investigating a possible dispute. Construction Safety Abroad: A worker died after an alleged fall at a building site in Vikhroli, with an FIR filed over alleged negligence and missing safety measures. Wellbeing at Home: A report highlights how adding plants to indoor spaces may support mood and focus, tying comfort and “nature” to everyday health.

Denmark Youth Safety: A 16-year-old is in custody after the stabbing death of another 16-year-old near a school party in Roskilde, with police saying a dispute may have come before the attack. Public Health & Nutrition: A new study in JAMA Network Open reports a low-fat vegan diet produced weight loss comparable to semaglutide over 16 weeks, adding to growing interest in plant-based approaches. Healthcare Policy Watch: In the U.S., public health groups are warning that a Trump executive order on childhood vaccines—splitting combination shots and expanding exemptions—could create major confusion and practical hurdles, despite no scientific basis cited. Women’s Rights & Health Access: The UN is urging donors not to cut funding for women’s programs in Taliban-ruled Afghanistan, warning that shortfalls could force many women’s organizations to suspend or close, worsening access to education, healthcare and support. Clinical Research & Longevity: Major pharma leaders are lining up for the ARDD 2026 meeting in Boston, reflecting the push to turn aging biology into therapies aimed at extending healthy years.

Wearables & Safety: Google’s Pixel Watch 5 adds breathing emergency detection that can call emergency services if oxygen drops and the wearer stays unresponsive, with limited availability in parts of Europe. Screen-Time Health: Japan’s Toyoake city found only about 5% of people cut smartphone/game use after a nonbinding “two hours a day” guideline, but the mayor says awareness must continue. Nutrition & Weight Loss: A new JAMA Network Open study reports a low-fat vegan diet produced weight loss comparable to semaglutide over 16 weeks, adding to growing interest in plant-based approaches. Aging & Longevity Science: Pfizer’s Ariel Feldstein and other leaders are set to speak at the ARDD 2026 meeting in Boston, highlighting the push to turn aging biology into therapies. Critical Care Nutrition: A quasi-experimental study discusses evidence-based nutritional protocols to improve outcomes for critically ill patients. Public Health Policy: Multiple reports focus on the fallout from U.S. executive actions on childhood vaccines, with experts warning about scientific and practical risks. Women’s Rights Funding: The UN urges donors not to cut funding for women’s programs in Taliban-ruled Afghanistan, warning many organizations may suspend operations. Allergy Watch: Research coverage links tick exposure to alpha-gal, a growing cause of red-meat allergy.

Vaccine Policy Shock: Multiple reports and fact-checks scrutinize Donald Trump’s executive order to split the MMR shot into separate measles, mumps and rubella appointments, with critics warning it would add costly logistics and more visits while offering no credible link to autism. Wearable Safety Tech: Google’s Pixel Watch 5 adds breathing emergency detection—calling emergency services if oxygen drops and the wearer stays unresponsive—rolling out in select European markets. Denmark-Linked Health Research: A Danish company Evaxion will share its Q2 2026 business update and results on Aug. 20, as it advances AI-driven vaccine work. Obesity & Diet Evidence: A new JAMA Network Open study reports a low-fat vegan diet produced weight loss comparable to semaglutide over 16 weeks, fueling debate on nutrition’s role in metabolic health. Space Diagnostics: Redcliffe Labs and Skyroot Aerospace plan a 90-day space test of diagnostic reagents to see how the environment affects stability and performance. HIV Progress Spotlight: UNAIDS highlights Cambodia’s progress toward 95-95-95 targets, noting Denmark among the countries reaching the goals. Local Health Context: Portugal research finds 18-year-olds spending more time online, especially on social media—raising questions about youth wellbeing.

Denmark & Global Health Policy: Denmark’s Ministry of Mineral Resources says a Texas-linked Greenland Energy project shipped drilling equipment to Greenland without authorization, prompting Nuuk to issue a “strong warning” and consider next steps as Greenland weighs licensing versus refusal. Public Health & Vaccines: A new U.S. executive order would cut recommended childhood vaccines and split MMR into separate injections, raising concerns about extra visits, costs, and strain on pediatric care—while experts say there’s no scientific basis. Weight Management & Nutrition: A JAMA Network Open trial reports a low-fat vegan diet produced weight loss similar to semaglutide over 16 weeks, adding to growing interest in plant-based approaches. Cardiology Research (Denmark): A Danish registry study examines how heart failure phenotypes are identified across age groups, highlighting ongoing challenges in phenotype misclassification. Digital Wellbeing: A Portugal-based study finds 18-year-olds are spending more time online, especially on social media, with many starting internet use before age 16. Capacity Building (Denmark-linked): KCMC University and the University of Copenhagen launch a 5-year program to train at least 16 specialists in immunology and vaccine manufacturing in Tanzania.

Child Vaccines Under Fire: In the U.S., Trump’s executive order would push separating MMR shots and spacing routine vaccines, but public health experts warn it’s not scientifically grounded and could create major financial and logistical burdens for families and providers. Obesity Treatment Debate: Novo Nordisk CEO Mike Doustdar tells Reuters obesity drugs won’t be a simple “winner-take-all” fight, arguing patient preferences and future options (including pills) will drive differentiation. Weight-Loss Diet Study: A JAMA Network Open trial found a low-fat vegan diet produced weight loss similar to semaglutide over 16 weeks, adding to growing interest in plant-based approaches. Mental Health & Learning: Research in the European Journal of Pediatrics links parental mental illness in early life to slightly lower cognitive scores in young men, with the effect changing when other hardships are present. Denmark Policy Update: Denmark has published six categories of foreigners who can apply for citizenship without meeting the standard employment requirement. Denmark Health Tech/Industry: Copenhagen Infrastructure Partners and partners back a Danish-owned data centre in Esbjerg focused on integrating with the local energy system.

Obesity Drug Race: Novo Nordisk CEO Mike Doustdar says obesity treatment won’t be a winner-take-all fight with Eli Lilly, arguing patients will choose among differentiated options as more medicines and pills arrive. FDA & Supply Chain: Novo Nordisk also faces an FDA setback over quality-control issues at U.S. production sites, creating delays but potentially opening room for Korean CDMOs. Blood Cancer Deal: Zealand Pharma sold its economic rights to Takeda’s rusfertide for $100M ahead of an FDA decision, keeping a small royalty stake if sales exceed a threshold. New Care Tech: Google’s Pixel Watch “Breathing Emergency Detection” is now available on Pixel Watch 4 as well as 5 in multiple European countries, with automatic emergency calling if a wearer can’t respond. Cancer in Older Patients: A Nordic population study reports first-line AVD chemotherapy may improve progression-free survival in older classical Hodgkin lymphoma patients versus ABVD, though overall-survival differences weakened after further adjustment. Public Health Policy Shock: A U.S. executive order would unbundle childhood vaccines like MMR and force more visits and new manufacturing capacity—experts warn it lacks scientific basis and is logistically daunting. Denmark in the World: Denmark and ASEAN launched a five-year partnership framework covering trade, climate adaptation, energy transition—and health, biotechnology and smart cities. Urban Health & Living: Copenhagen plans to repurpose its former municipal hospital into mixed-use housing and public spaces, aiming to bring everyday amenities into historic surroundings. Air Pollution Risk: Greenland’s Ilulissat port shows extremely high ultrafine particle levels, raising stroke, heart and lung disease concerns and pushing calls for electrified port equipment.

Weight-loss & diet research: A new JAMA Network Open study reports a low-fat vegan diet produced weight loss comparable to semaglutide over 16 weeks, adding to growing interest in plant-based approaches for metabolic health. Reproductive health: Danish researchers say body fat percentage may predict reduced sperm count and hormone changes better than BMI, even in men with “normal” BMI. Vaccines & policy: WHO officials criticized a new U.S. executive order pushing fewer childhood vaccines and splitting MMR, warning it’s politically driven and contradicts science. Public health enforcement: Eli Lilly sued companies selling knockoff retatrutide, calling the black market an urgent public health crisis. Mobility care (Denmark-linked): Enable Me, using VA funding, highlights Danish-engineered VELA chairs for veterans with long-term mobility challenges. Drowning prevention: Sweden launched a national drowning research centre to cut high death rates by improving prevention and emergency care. Prison violence ruling: A Hungarian court ordered compensation after guards beat a prisoner so badly his spleen had to be removed.

Vaccine Policy Shock: In the US, President Trump signed an executive order to cut the number of childhood vaccines and split MMR into separate shots, despite major medical groups warning it isn’t science-led and could lower uptake and fuel outbreaks. Phage Therapy Breakthrough (Denmark): SNIPR Biome reported a peer-reviewed expanded access case where its engineered CRISPR-enhanced phage therapy (SNIPR001) helped a kidney transplant patient with multidrug-resistant E. coli malakoplakia, with major lesion shrinkage and no phage-related adverse events. Weight-Loss Nutrition Study: A new JAMA Network Open trial found a low-fat vegan diet produced weight loss comparable to semaglutide over 16 weeks, adding to growing interest in diet as a treatment lever. Hearing Tech in Focus (Denmark): GN Hearing launched ReSound Sensia, claiming AI-driven clarity in noisy environments with improved speech audibility. Heart Device Pipeline (Denmark-linked): Anteris Technologies said it advanced its PARADIGM trial, expanding recruitment across US, Denmark and the Netherlands after securing key reimbursement eligibility. Gut Health & Food Additives: A review in Nutrients links ultraprocessed food additives to gut microbiome disruption and a more inflammatory intestinal barrier.

Childhood Vaccines Under Fire: US President Donald Trump signed an executive order to cut the routine childhood vaccine list from 18 to 11, space doses across more visits, and split the MMR into separate shots—sparking confusion for parents and pushback from major medical groups, with legal and state-level implementation still unclear. Pharmacy Workflow Update: A Danish-linked study reports pharmacists are broadly positive about electronic prescription transfers, but flag practical hurdles like patient understanding, pharmacy reimbursement for printing, and reduced time with prescribers. Arthritis Treatment Differences Across Europe: EuroSpA research suggests country income levels may shape when patients with psoriatic or axial spondyloarthritis start advanced biologic/targeted treatments and how long they stay on them. Brain Imaging for Huntington’s: New MRI-based modelling can detect microstructural brain changes tied to Huntington’s disease, aiming to improve monitoring and support trials. Weight-Loss Drug Access in Europe: The UK approved Eli Lilly’s oral GLP-1 orforglipron for obesity/Type 2 diabetes, though NHS availability depends on cost rules. Digital Health Accessibility: US guidance highlights that patient check-in and payment kiosks must meet disability access obligations under ACA Section 1557. Coagulation Research Moves: Hemab Therapeutics reported progress across its blood-clotting pipeline and shared new trial updates at a major thrombosis congress.

Guillain-Barré Breakthrough: Annexon says early FORWARD cohort results for tanruprubart show rapid, clinically meaningful muscle strength improvement within 4 days after a single infusion, with the company positioning the approach as targeting neuroinflammation. Vaccine Policy Shock: In the US, President Trump signed an executive order that would cut routine childhood vaccines from 18 to 11 and split MMR into separate shots, despite major scientific pushback and repeated claims about autism that have been widely debunked. TB Vaccine Momentum: The TB vaccine pipeline is accelerating, with M72/AS01E in a large phase 3 trial and new manufacturing plans aimed at enabling the first major TB vaccine advance in more than a century. Weight-Loss Drug Watch: UK regulators have approved Eli Lilly’s orforglipron (Foundayo) for weight management and type 2 diabetes, while the NHS decision is expected later this year. AI in Healthcare Ops: New Orleans is deploying AI to triage emergency calls and reduce repetitive requests, supporting human operators during real-world testing. Climate & Health Risk: A Europe-wide review links heavy rainfall and flooding to infectious disease risks and highlights gaps in surveillance and preparedness. Methane Feed Additives: Research suggests public resistance to chemical methane-mitigating additives like 3-NOP could slow dairy rollout unless communication is carefully tailored. Cancer Research: University of Copenhagen-led work points to a new synthetic-lethality vulnerability in colorectal cancer via the NDRG1–VCP interaction, with quinacrine flagged as a potential starting tool compound.

Child Vaccines Policy: Trump signed an order to cut the number of universally recommended childhood vaccines in the U.S. from 18 to 11 and to reassess timing within 90 days, while repeatedly linking the change to autism despite decades of research finding no vaccine-autism link. GLP-1 Market & Tech: Novo Nordisk is partnering with AWS to build an AI drug-discovery hub in London, aiming to speed early research and development as it also pushes its Wegovy pill rollout and faces shifting pricing pressure. Drugmakers’ U.S. Push: Reuters reports major global pharma firms are pledging hundreds of billions in U.S. investments to expand manufacturing and reduce supply-chain risk, including Eli Lilly’s multi-plant plans. Real-World Prostate Cancer Care: A Veterans Affairs study in metastatic prostate cancer compares enzalutamide vs abiraterone, suggesting similar overall outcomes with a possible survival edge for older patients on enzalutamide. Denmark Pharma Buyback: Zealand Pharma disclosed share buy-back transactions for week 32 under its DKK 1.3bn program. Public Health & Access Tech: New Orleans is deploying AI to triage emergency calls, reducing repetitive calls handled by human operators. Health-Related Allergy Alert: Tick bites can trigger alpha-gal syndrome, causing delayed allergic reactions to red meat and dairy hours after exposure.